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Abstract. Aging is associated with both muscle weakness and a loss of muscle mass, contributing towards overall frailty in the
elderly. Aging skeletal muscle is also characterised by a decreasing efficiency in repair and regeneration, together with a decline
in the number of adult stem cells. Commensurate with this are general changes in whole body endocrine signalling, in local
muscle secretory environment, as well as in intrinsic properties of the stem cells themselves. The present review discusses the
various mechanisms that may be implicated in these age-associated changes, focusing on aspects of cell-cell communication
and long-distance signalling factors, such as levels of circulating growth hormone, IL-6, IGF1, sex hormones, and inflammatory
cytokines. Changes in the local environment are also discussed, implicating IL-6, IL-4, FGF-2, as well as other myokines, and
processes that lead to thickening of the extra-cellular matrix. These factors, involved primarily in communication, can also
modulate the intrinsic properties of muscle stem cells, including reduced DNA accessibility and repression of specific genes by
methylation. Finally we discuss the decrease in the stem cell pool, particularly the failure of elderly myoblasts to re-quiesce
after activation, and the consequences of all these changes on general muscle homeostasis.
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INTRODUCTION
Over the last 60 years, work performed on animal
models, chiefly mouse, rat, and avian, and on human
samples, has revealed and explored the capacity of
adult stem cells - also called somatic stem cells – to
self-renew and to differentiate into unipotent progeny
within their residing tissue [1], generally for the pur-
pose of repair. Resident stem cell populations have now
been described in most tissues, including bone marrow
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[2], blood vessels [3], peripheral blood [4], skin [5],
teeth [6], gut [7], liver [8], heart [9], brain [10] and
skeletal muscle [11]. Once body growth has stopped
and adulthood is reached, most of these stem cells
become quiescent, and will only be activated for tissue
turnover. Although this turnover can be very active as
in circulating blood or gut epithelium in other tissues
such as liver the stem cells usually remain unsolicited
as hepatic damage rarely occurs in healthy adults [8].
Despite this heterogeneity, a decline in number and
properties is universally observed in aged stem cells,
a phenomenon which alters the maintenance of tissue
homeostasis with aging. In aged skeletal muscle, a tis-
sue with low turnover, this decline in the adult stem
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cell (also called satellite cell), which is responsible for
muscle repair [12], is associated with muscle atrophy
and muscle weakness [13–15], although their deple-
tion in the mouse has differential effects depending on
the muscle [12].
Muscle stem cells or satellite cells are localized
beneath the basal lamina, peripheral to the muscle
fibers [11], and express Pax7 [16] and Notch3 [17].
After muscle injury, satellite cells are driven out of
their quiescent state, and start to proliferate. Most of
the activated satellite cells rapidly co-express MyoD
or Myf5 [16, 18]. The proliferating satellite cells - also
called myogenic precursor cells or myoblasts - expand
under the control of Notch3 [17] and Notch1/Hey1
pathways [19, 20]. They divide asymmetrically, with
self-renewal of the stem cell pool being maintained by
a minor population of myogenic precursor cells that
down-regulate their expression of MyoD and Myf5
and return to a quiescent state [18, 21–23]. This asym-
metrical division involves Numb, an antagonist of the
Notch signalling pathway [19, 24]. Numb is asymmet-
rically localized during myoblast mitosis and it is the
cell that has a high level of Numb that goes back to
quiescence for self-renewal [19, 24–26]. After several
rounds of proliferation, activated myoblasts decrease
their expression levels of Pax7, Myf5 [16, 18] and
Notch3 [17]. The Notch1 pathway is then repressed
by Stra13 [20] through the CBF1 pathway [20, 27].
Simultaneously, the Wnt pathway is activated and
promotes myoblast differentiation through -catenin
[28]. Myoblasts exit the cell cycle by expressing p57
[29], and then cyclin inhibitors - p21 and hypophos-
phorylated pRb [30–32] - together with higher levels
MyoD followed by myogenin, a driver which trig-
gers the expression of the differentiation genes [33,
34]. The myoblasts consequently undergo differenti-
ation into myocytes, and fuse either with each other
or with existing multi-nucleated myofibers in order
to repair injured muscle [35, 36]. The differentiation
and maturation process is regulated by MEF2, MEF3,
and Mrf4 pathways [37–39], while other factors, such
as Myomaker, are involved in fusion [40]. Muscle
precursor cell proliferation, fusion and differentiation
are tightly orchestrated by circulating hormones (e.g.
growth hormone [41], testosterone [42, 43] and thyroid
hormones [44, 45]), growth factors (e.g. IGF system
[41], FGF system [46–48], TGF-b [49, 50]), G-CSF
[51], chemokines (e.g. interleukines [52–55], MPC
[55, 56]) and other secreted components (e.g. vesicles
[57, 58]) present in the muscle stem cell environment.
Aged human [59] or murine [60–62] muscle can
regenerate and repair, although the rate of regeneration
declines [60–62]. This slower regeneration can be
explained by: (1) changes in the muscle stem
cell environment (growth factors, growth hormones,
inflammation, and extracellular matrix content); (2) a
lowered responsiveness of progenitor cells to repair
stimuli; and (3) decrease in the number of muscle stem
cells with aging. Each of these factors may impact on
muscle homeostasis and each may both participate to,
and be affected by, age-associated changes in inter-
cellular communication. The subsequent sections will
describe the different roles that intercellular communi-
cation may play in muscle aging, from hormonal and
other circulating endocrine factors to local paracrine
and autocrine secretory environment of the stem cell
niche that may also modify the intrinsic properties of
the stem cells themselves.
HORMONAL AND OTHER CIRCULATING
FACTORS: CHANGE IN ENDOCRINE
COMMUNICATION WITH AGING
The decline in muscle regenerative capacity with age
[63] has been partly attributed to a decline in extrinsic
environmental cues (see Fig. 1). Levels of circulating
hormones, such as testosterone or IL-6 or growth hor-
mone (GH) or IGF-1, are low in serum samples of aged
subjects [64–66].
The endocrine hypothalamic-pituitary axis is altered
with aging, leading to changes in hormone secretion
that can contribute to cognitive decline or depression.
Epidemiological studies have also shown a correlation
between the decrease in growth hormone (GH) secre-
tion and sarcopenia as well as other signatures of aging
(e.g. intra-abdominal adiposity, osteopenia, etc.) [67].
GH is a stress hormone produced by the hypothalamus.
It plays a key role in muscle mass maintenance through
life [66]. It acts on myoblasts through its receptor GHR
and activates NFATc2 that in turn stimulates the expres-
sion and secretion of IL-4 [41, 68, 69] - IL-4 being
critical for myoblast fusion [68, 69]. GH also stimu-
lates IGF-1 secretion by both liver and muscle [66].
IGF-1 and its splice variants - IGF-1Ea and IGF-1Eb -
modulate myoblast proliferation [70] and differentia-
tion [71] through MAPK and ERK1/2 signalling [70].
The latter regulates myogenesis, for example by inter-
acting with p38MAPK and the asymmetric division
and self-renewal of satellite cells [72].
These age-associated changes in the endocrine
hypothalamic-pituitary axis can have further effects
on the gonadotropic axis. Sex-steroid privation associ-
ated with age participates to, among other phenomena,
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Fig. 1. Age alters serum composition and thereby affects intercellular communication at distance. The endocrine hypothalamic-pituitary axis is
altered with aging, affecting the composition of circulating hormones in the serum. For instance, the secretion of growth hormone is decreased,
leading to loss of muscle mass. In addition, the lower level of growth hormone will also stimulate less the secretion of IGF-1 - IGF-1 being involved
in muscle mass maintenance and in the satellite cell myogenic program. The endocrine hypothalamic-gonadotropic axis is also affected, leading
to a decrease of sex steroids such as Testosterone, another hormone involved in muscle mass maintenance. Similarly, a decrease in oestrogen
can act on the myogenic program through IGF-1 signaling. The decrease in circulating hormones affects the capacity of the satellite cells to
respond to muscle damage. Aging is also associated with an increase in inflammation. The cytokines secretion by aged inflammatory cells as
well as their ROS production is modified and can also affect the capacity of the satellite cells to respond to muscle damage. The modification
of the entire serum composition with aging has negative effects on muscle mass and on muscle regeneration capacity.
loss of muscle mass [67]. The sex-steroid testosterone,
secreted by the testis, has been extensively studied
in muscle, and can be considered as a double-sided
blade, acting both on myoblast proliferation and dif-
ferentiation. It acts on myoblasts through the androgen
receptor localized in the nucleus [73] or through G
protein-coupled receptors [74]. It promotes myoblast
proliferation through protein kinase C (PKC) signaling
[74] - for instance through nPKCδ and extracellular
signal-regulated kinases 1 and 2 (ERK1/2) activation
[75]. Once ERK1/2 is phosphorylated, it is accompa-
nied by an increase in cyclin E and Cdk2 – which are
involved in myoblast proliferation [76]. Testosterone
acts also on myoblast differentiation via protein kinase
A (PKA) signaling [74] - PKA being required for
myoblast fusion [77, 78]. Interestingly, oestrogens act
similarly on the myogenic program through IGF-1
signaling [79].
Aging is associated with an increase in low grade
chronic and systemic inflammation, also called inflam-
maging [80]. Inflammaging could be due to microbial
infection, cell debris, over-activated coagulation sys-
tem, or an increase in cellular senescence with the
associated changes in secretion [80]. This increased
inflammation is generally attributed to a modified
immune partner. Indeed, while young macrophages
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have been shown to have a beneficial effect to clear
muscle debris after injury and stimulate myogenesis
[81–83], aged macrophages can release a higher level
of osteopontin that inhibits the muscle regeneration
process [84]. Not only macrophages are involved in
the muscle regeneration process, but also neutrophils,
lymphocytes, dendritic cells, etc. These inflammatory
cells secrete numerous chemokines and cytokines, but
little is known about the impact of aging on cytokine
secretion [85]. In the literature, it is described that IL-
6 serum level is decreasing during aging [65]. IL-6
originates from the inflammatory cells, but also from
the skeletal muscle itself [86]. It has been shown to be
an important regulator of muscle stem cells [53], as it
activates janus kinase 2 (Jak2) that will in turn phos-
phorylate STAT3 [52]. Once STAT3 is phosphorylated,
it homodimerizes and translocates to the nucleus to
bind to the -interferon activation sequence [87] in the
promoter regions of genes involved in myoblast pro-
liferation such as c-myc [52]. IL-6 not only regulates
myoblast proliferation, but also promotes myoblast dif-
ferentiation through the p38 MAPK pathway [88]. A
decrease in IL-6 serum level could thus impact muscle
regeneration efficacy.
The tissues from which circulating factors origi-
nate, such as muscle, hypothalamus, gonads, and liver,
become atrophic and less active with age [8, 66, 89].
This change in body composition and activity with
aging can thus participate to the decrease in circulat-
ing hormones (see Fig. 1). Consequently, when muscle
damage occurs in an aged person, satellite cells be
less prone to activation and differentiation, leading to
a less efficient repair. Ten years ago, Conboy et al.
elegantly showed that muscle regeneration could be
partly rescued in aged mice exposed to serum from
young mice through a parabiosis system [90]. Sim-
ilarly, hormones released during pregnancy rescued
the muscle regenerative capacity of aged female mice
[91]. When aged subjects are trained, a rejuvenating
effect is observed on muscle. This benefit effect could
probably be due to a decrease of the inflammation for
instance, as observed in exercised patients affected by
myositis [92, 93]. When aged muscle stem cells were
engrafted into young mice [94], their capacities to pro-
liferate and differentiate were partly restored. Together
these data suggest that circulating agents, which can
originate from different tissues, impinge on muscle
regeneration efficiency. Aging affects both the size
and function of each tissue and consequently tissue
secretory capacity. This alters the composition of circu-
lating serum effecting intercellular communication at
distance.
SECRETORY ENVIRONMENT OF THE
STEM CELL NICHE: CHANGE IN
PARACRINE AND AUTOCRINE
CELL-CELL COMMUNICATION WITH
AGING
In addition to its classical role as a locomotive sys-
tem, skeletal muscle has recently been shown to have
a secretory activity. For instance, IL-6 [86] and mus-
culin [95] have been identified to originate from and
be secreted by skeletal muscle in vivo. In vitro, the
secretome profile of C2C12 myotubes [55, 56], human
myotubes [57] and rat muscle explants [96] suggest that
muscle cells secrete numerous growth factors (e.g. fol-
listatin like protein 1, IGF-2, TGF, etc) and cytokines.
Secreted proteins - also named myokines [95] - may
act in an autocrine/paracrine manner on neighboring
musclecellsandcontribute tomusclegrowthandregen-
eration. This local muscle secretome can be altered with
aging. For instance, Chakkalakal et al. have shown that
an increased secretion of FGF-2 by aged myofibers
in mice inhibits sprouty1 expression in satellite cells,
and consequently reduces their capacity to go back
to quiescence and replenish the pool of the muscle
stem cell [47]. The muscle secretome includes not only
hormones, but also extracellular matrix components
(ECM, e.g. TIMP2, fibronectin), miRNAs, and vesi-
cles (exosomes and microvesicles) [57, 58, 97, 98].
Interestingly, exosomes originating from differentiated
myocytes stimulate the myogenic program of prolif-
erating myoblasts [58]. Myocyte exosomes contain
miRNAs that inhibit Sirtuin expression, and thus stim-
ulate the myoblast differentiation into myotubes [98].
A decrease in muscle mass with aging may thus reduce
muscle secretory output. In a transcriptomic analysis
performed on quadriceps muscle from young (15–24
years old) and elderly (72–80 years old) subjects, we
indeed observed down-regulation of secretome mark-
ers in aged muscle [99]. However, little is known about
the changes in the composition of the muscle secretome
of aged muscle and further investigation is needed.
The local niche of muscle stem cells includes
growth factors and cytokines secreted not only by the
myofibers themselves, but also potentially by other
cell types present within muscle, such as fibroblasts,
endothelial or peri-endothelial cells [100, 101]. This
local secretome can also be altered with aging (Fig. 2).
For instance, fibroblasts present in aged skeletal muscle
express a high level of TGF- [101] – a growth fac-
tor that inhibits differentiation of myoblasts [102], and
thus slows down the regeneration process. In addition,
aging is described to be associated with an increase
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Fig. 2. Aging changes the microenvironment of the satellite cell. Decreased muscle mass can be accompanied by a decrease in myokines
and vesicles secreted into the microenvironment of the satellite cells. Aged myofibers produce more ROS and FGF-2, factors that can change
epigenetic marking of the satellite cells and shut down their myogenic program and their capacity to re-quiesce. They also release less NO into
their environment, stimulating vasoconstriction which may inhibit serum tissue perfusion. Aged fibroblasts present in the muscle can secrete more
fibrous proteins, thickening the ECM. In turn, this decreases the diffusion of growth factors toward the satellite cells and thus their responsiveness
to muscle repair cues. Increase in senescent cells with age can secrete factors that inhibit tissue regeneration. The microenvironment of the
satellite cells is thus altered and affects their capacity to respond to any muscle damage.
in senescent or pre-senescent cells in muscle and other
tissue [103, 104]. During the last decade, the secretome
of senescent cells from different tissues has been inves-
tigated and has been described to have an impact on
the inflammatory response (by stimulating it in chronic
obstructive pulmonary disease [105]) and to be instru-
mental in poor tissue regeneration (as observed in aged
skin [106]). Altogether, these data suggest that the
presence of senescent cells distinct from satellite cells
within muscle tissue could alter these microenviron-
ment of the satellite cells, and thus their behavior.
Muscle perfusion is decreased with aging [107],
which may render myofibers and satellite cells less
accessible to circulating hormones. This loss of per-
fusion may be maintained by the muscle loss itself.
Indeed, sarcopenic muscle presents a disruption of the
dystroglycan complex [108], leading to NOS-1 mis-
localization, due to the link of NOS-1 to the dystrophin
protein [109]. The mis-localization of NOS-1 results
in decreased NO production, thereby diminishing
muscle perfusion [110]. A second effect of decreased
NO production is a reduction in satellite cell activation
[111].
Aged skeletal muscle presents a thickening of the
ECM and a general increase in fibrosis [112]. Even
if muscle fibers can secrete collagens and other com-
ponents of the ECM [57, 97], little is known about
their role in ECM thickening. A recent study shows
that fibroblasts present in aged rat muscles express a
higher level of collagen IVa2 and laminin 2 – which
may participate in the thickening of the ECM [101].
This increase in the ECM thickness can interfere
with the muscle regeneration process by modifying
myoblast activation, proliferation and migration [48,
113]. Finally, a thickened ECM may act as a par-
tial barrier, reducing the accessibility of the satellite
cells to circulating growth factors, as observed for
smooth muscle cells [114], and thus impair satel-
lite cell activation and differentiation during muscle
repair.
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Together, these data suggest that the changes in
the secretory composition of the muscle stem cell’s
local niche with aging can slow down the regeneration
process and decrease the replenishment of the pool of
reserve cells. Repetitive iterations of this could con-
tribute to the loss of muscle stem cells with aging.
CHANGE IN THE INTRINSIC PROPERTIES
OF STEM CELLS WITH AGING
Exposure to a young environment by engraftment
into young subjects or by parabiosis experiments only
partly rescues the properties of aged satellite cells [90].
For instance their capacity to replenish the pool of
reserve cells is not rescued (our unpublished data and
[115]). These data suggest that some intrinsic proper-
ties of satellite cells are altered with aging and are not
easily manipulated by external cues.
Intrinsic properties rely at least partly on DNA
methylation, which may regulate gene expression
in two ways [116]: (1) the accessibility of methy-
lated enhancer regions to transcription factors is
reduced, resulting in gene expression repression;
(2) methyl-CpG-binding proteins bind to methylated
DNA and alter the activity of histone deacetylases
and methyltransferases. Consequently, local histones
are hypermethylated, stabilizing the nucleosomes, so
that DNA in methylated regions is tightly packed
preventing binding of transcription factors or RNA
polymerases. A recent study shows that histone methy-
lation patterns are different between aged and young
satellite cells in mice [117], and that the methylation
profile can be modified by the presence of local growth
factors such as FGF-2 [118]. The authors associated
this histone methylation profile to a slower capacity of
aged satellite cells to re-enter the cell cycle for aged
satellite cells [117]. Interestingly, this study [117], as
well as our own observations on culture of aged human
muscle stem cells, show that once activated, aged satel-
lite cells have a similar myogenic potential to young
satellite cells. This indicates that muscle stem cells do
not lose their differentiation potency with age, suggest-
ing that the decrease with aging in the differentiation
program during muscle regeneration is strongly related
to changes in circulating factors.
DNA methylation has been shown to be increased
in several tissues with aging, and the skeletal muscle
is no exception [119, 120]. We have observed a higher
level of DNA methylation in satellite cells of aged sub-
jects (unpublished data). This hypermethylation could
impact on the satellite cell fate and interfere with their
capacity for self-renewal as observed in previously
published studies (our data and [47, 115]). How DNA
methylation is regulated with aging is not well known.
Repeated stress over time can be one of the parame-
ters implicated [121], involving for instance reactive
oxygen species (ROS) [122]. Increased ROS produc-
tion with age can be due to an increase in inflammation
with aging [80] or to mitochondrial dysfunction in aged
muscle [123, 124]. A decrease of circulating GH is also
associated with a higher level of ROS and a lower level
of anti-oxidants [125]. This overproduction of ROS
could participate to increased DNA damage observed
with aging [126]. Consequently, DNA methyltrans-
ferases (DNMT) are recruited to the DNA damage
site, potentially inducing DNA silencing of the region
nearby [127]. When we re-analyzed the transcriptome
data available online (GSE9103), we indeed confirm
a significant enrichment in the cellular response to
oxidative stress in aged muscles (Fig. 3), suggesting
a higher stress in aged muscle. ROS diffuse easily
through membranes of fibers, thus potentially affect-
ing DNA damage in neighboring satellite cells, and
modifying their methylation status.
Factors discussed above - changes in the composi-
tion of circulating hormones in serum, as well as in
the microenvironment - could also modify the epige-
netic status of satellite cells and thus their behavior
during regeneration, slowing satellite cell activation
and decreasing their capacity to go back to quiescence
THE LOSS OF MUSCLE STEM CELLS
WITH AGING AND ITS CONSEQUENCES
ON MUSCLE HOMEOSTASIS
The number of muscle stem cells declines with
age in mouse [13, 47, 90, 94] and humans [128,
129]. Although this loss can be caused by an increase
in cell death, cellular senescence, or a deficiency in
re-quiescence, apoptosis is rarely observed in aged
murine and human muscle stem cells [94, 130, 131],
suggesting that this cannot by itself explain the loss
of muscle stem cells with aging. However, we cannot
exclude the fact that apoptosis is a short punctual event
that may be missed experimentally. Cellular senes-
cence - also called replicative senescence - is defined
as a phenomenon by which normal diploid cells cease
to divide. It can be induced by telomere shortening
that occurs during cell proliferation, and has been pro-
posed to contribute to the loss of satellite cell function
with aging [103]. However, shortened telomere length
has not been reported in aged human satellite cells.
M. Thorley et al. / Cell-Cell Communication with Age in Muscle Stem Cells 211
Fig. 3. Increase of oxidative stress response in aged muscles. For this analysis we retrieved the gene expression matrix of old and young muscles
of sedentary subjects (series GSE9103 from the Gene Expression Omnibus [139]). We discarded three samples as they did not pass the quality
control threshold. To identify differentially expressed genes we used the characteristic direction method [140] followed by gene set enrichment
with Enrichr [141]. The top figure depicts a bar graph from the top 10 up-regulated GO Biological Processes (combined score: p-value multiplied
by z-score) and the bottom figure a network of the same Processes, where each node represents the enriched term and the edges represent the
gene content similarity between the nodes.
Furthermore, there may be insufficient activation and
turnover of satellite cells to allow senescence to be a
major contributor to stem cell decline. Satellite cells
are rarely activated in healthy adult human or mouse,
and once muscle growth is complete in young human
adults [14], subsequent myonuclear turnover is slow,
being estimated at 15 years during adulthood [132]. In
mouse models, myofiber growth by the addition of new
nuclei through satellite cell fusion is completed by 21
days postnatally [133], and there is little evidence to
suggest significant turnover. As discussed earlier, the
capacity to re-quiesce through the sprouty1 pathway is
decreased in aged stem cells [47, 117]. Consequently,
when satellite cells are activated for muscle repair
in elderly subjects, they do not replenish the pool of
reserve cells. This failure of re-quiescence is a likely
contributor to stem cell population decline.
The decrease in the number of satellite cells with
aging can affect muscle homeostasis by altering the
ECM composition. Indeed, aged muscle depleted in
satellite cells in a Pax7CreER-DTA murine model shows
an increase in fibrotic deposition [134], while fiber
size was unaffected [135]. Resulting thickening of the
ECM may increase myofiber fragility, and reduce the
response of satellite cells to muscle damage, as dis-
cussed earlier. Therefore a loss of satellite cells could
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Fig. 4. Links between whole-body composition changes, the decline of muscle size and function, and the loss of muscle stem cells and their
functions with aging. Modifications with age of the endocrine systems (hypothalamus-pituitary system, gonad glands, liver, etc.) affect the
quantity and the content of circulating serum hormones and impact muscle mass maintenance (atrophy of the muscle fibers and decrease in
the regenerative capacity of the muscle). Increased inflammation with age - also called inflammaging - affects whole body stress level and
is accompanied by modification in secreted cytokine content. Increased oxidative stress of the muscle leads to DNA damage and epigenetic
changes, and consequently affects the regenerative capacity of the muscle. The composition of the microenvironment of the satellite cells is
affected with age, through the presence of aged fibroblasts, of senescent cells, and aged myofibers. These local changes contribute to the fragility
of the myofibers and to a decrease in the regenerative potency.
impinge directly upon muscle homeostasis, and exac-
erbate muscle fragility with aging.
CONCLUSION
The interplay between whole-body tissue compo-
sition, the quantity and content of circulating serum
hormones, and whole-body stress, such as ROS pro-
duction, changes with age, and contributes to the
decline in muscle mass and function (Fig. 4). Increased
stress can act through epigenetic marking of satellite
cells, changing their intrinsic properties with age -
aged satellite cells show a decrease in their activation
rate due to epigenetic changes. In addition, satellite
cell number is decreased during aging, a loss that can
contribute not only to a decreased regenerative capac-
ity, but also to an increase in fibrotic deposition and
ECM thickening. Increased muscle stiffness renders
myofibers more fragile, requiring the activation of an
already reduced and less responsive satellite cell pop-
ulation. Age-associated changes in the local signalling
environment can affect the myogenic program causing
a lower regeneration efficacy, a decrease in myonuclear
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turnover, and a failure in replenishing the pool of
reserve cells, further contributing to the loss of mus-
cle mass. Changes in the whole system of intercellular
communication – both at the whole-body scale and in
muscle microenvironment – may thus act as a vicious
circle to exacerbate sarcopenia as the body ages. It is
noteworthy that most studies on muscle aging in the
literature have been done on muscle stem cells, rather
than myofibers, and thus emphasize the role of satellite
cells in muscle mass maintenance. The effect of hor-
mones and cytokines and more generally the effect of
aging on myofibers is difficult to assess directly and
should not be neglected. The myofibers themselves
comprise the bulk of the muscle mass and are clearly
a key part of the maintenance of their own mass with
aging, as indicated by disequilibrium of protein synthe-
sis and degradation or the expression of micropeptides
such as myoregulin that have a key role in muscle
performance [138].
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